Barcelona-based IOMED secures €10 million to champion healthcare ecosystems with real-world data
Summary
IOMED, a leader in AI-powered technology for healthcare data activation, has recently announced the closure of a Series A investment round for a total of €10 million. The company has also received a grant of nearly €1 million from red.es to support a research and development project in artificial intelligence. This milestone represents the consolidation of the company as a leader in the healthcare technology sector and clear evidence of its unique value proposition. This funding round will enable IOMED to expand internationally, consolidate its position in the current market, and fortify the foundations for the company’s sustainable growth. Its technology activates data from both structured and unstructured sources, thanks to their Natural Language Processing System.